Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

Based in Kuala Lumpur, Aman brings over two decades of HR experience across industries like finance and pharma. To him, ...

GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support ...

GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial ...

GSK PLC closed 11.51% short of its 52-week high of £16.79, which the company achieved on September 9th.

GSK PLC GSK shares dropped 2.45% to £15.12 Friday, on what proved to be an all-around poor trading session for the stock ...